Vystar Corporation Stocks

$ 0.06Last Updated 17.03.2026

Issuer Rating

3/7

Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 1.04M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0.06
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Vystar Corporation manufactures and sells air purifiers in the United States. The company offers RXair, a residential filterless air purifier; RX400, a food and drug administration (FDA) cleared class II filterless air purifier; and RX3000, a commercial FDA cleared class II air purifier. It also manufactures and sells Vytex natural rubber latex products to the manufacturers of rubber and rubber end products; and manufacturers of a range of consumer and medical products, such as adhesives, gloves, balloons, condoms, and other medical devices, as well as natural rubber latex foam mattresses, toppers, and pillows. In addition, the company sells a range of residential furniture and decorative accessories through its independent furniture stores. It sells air purifiers through distributors and retail channels, as well as online. The company was founded in 2000 and is based in Worcester, Massachusetts.

Company Valuation

Undervalued
6/7

Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks